lenalidomide
NDC 69097-385, lenalidomide, capsule, from Cipla USA Inc..
- Product NDC
- 69097-385
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210435
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-385 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LENALIDOMIDE25 mg/1
Pharmacologic classes
Thalidomide Analog [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-385-81 | 69097038581 | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ba2a07fd-ca60-40bc-b79b-9caf81900fa3
Use it
Look up 69097-385 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-385 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-385. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.